Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Marina Biotech presents novel nucleic acid complexes

Oct. 28, 2011

TopoTarget patents new nicotinamide phosphoribosyltransferase inhibitors

Oct. 28, 2011

New Wnt signaling inhibitors discovered in Germany

Oct. 28, 2011

Adventrx and FDA agree on pivotal ANX-514 trial

Oct. 28, 2011

S*BIO plans phase III program for pacritinib

Oct. 27, 2011

Solasia Pharma begins study of darinaparsin injection in Japan

Oct. 27, 2011

Immunovaccine clear to start phase I/II DPX-Survivac trial in Canada

Oct. 27, 2011

Avila Therapeutics describes new BTK inhibitor

Oct. 27, 2011

DelMar Pharmaceuticals commences phase I/II trial of VAL-083

Oct. 26, 2011

FDA grants IND clearance for phase II trial of Aeterna Zentaris' AEZS-108 in breast cancer

Oct. 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...